Honorary President
Thom Browne Jr. is President and CEO of Rubicon Global Enterprises. He provides global technical assistance on drug prevention, treatment, recovery, and criminal justice issues. He chairs international working groups to develop certification for addictions counselors, licensing for treatment centers, and networks of treatment/prevention professionals. He serves as expert advisor to selected international organisations on counter-narcotics issues. He has developed specialised programmes addressing unique international challenges such as identification of toxic adulterants added to drugs of abuse and related public health responses.
He also works as Chief Executive Officer at the Colombo Plan Secretariat. He assists the Secretary General with setting organisation strategy, strategic plans, and vision/mission statements; mentors staff to develop skills for effective programme management and professional growth; identifies opportunities for programme expansion; identifies funding opportunities and potential donors; advises on design, marketing, promotion, delivery, and quality of programmes, products, and services; and assures the organisation and its mission, programmes, products, and services are consistently presented in strong, positive images to relevant stakeholders.
Prior to that he was the Deputy Director of the Office of Anticrime Programmes at the U.S. Department of State, Bureau of International Narcotics and Law Enforcement Affairs. He was responsible for formulation, coordination, and implementation of State Department strategies and programmes for drug prevention and treatment, international crime, and international law enforcement training academies. He promoted U.S. policy interests in bilateral and multilateral forums such as United Nations, Organisation of American States, and the Colombo Plan. He developed collaborative drug prevention/treatment and anti-crime projects with donor countries and regional/international organisations.
He developed specialised programmes addressing unique international challenges such as child drug addiction, crack cocaine addiction, expanded treatment services for women and their children, specialised training curricula for women’s addiction, identification of toxic adulterants added to drugs of abuse and related public health responses, and national-level certification of addictions counselors.
Prior to that he worked as Senior Policy Analyst in the Programme Planning Unit of the U.S. Department of Justice, Drug Enforcement Administration. He served on interagency working groups to develop comprehensive drug control strategies. He formulated extensive research projects and special reports on cocaine, crack, designer drugs, heroin, cannabis, and clandestine laboratories. He was responsible for assessments and estimates of foreign drug production, flow, availability, and consumption of illicit drugs.
He holds an MA in Criminal Justice Administration from the University of Maryland.